Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Canaccord Genuity

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Ethereum Is 'Blue Chip Blockchain,' Could See Significant Value Boost: Canaccord Analysts

Cryptocurrency Ethereum (CRYPTO: ETH) and the smart contract ecosystem were sized up by Canaccord Genuity in a new note.

Benzinga

Salesforce Faces Price Target Cuts On Guidance Cut, Shares Slide

Salesforce Inc (NYSE: CRM) reported upbeat results for its second quarter, but lowered its annual projections.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022

Benzinga

This MicroStrategy Analyst Is Slashing Their Price Target After $1B Loss, Michael Saylor Steps Down

MicroStrategy (NYSE: MSTR) recently reported a net loss of more than $1 billion in the second quarter compared with a loss of about $299.3 million in the same period last year.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Tesla Whale Trades For July 29

Someone with a lot of money to spend has taken a bearish stance on Tesla (NASDAQ:TSLA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Check Out What Whales Are Doing With Tesla

Benzinga

Here's Why Accolade Shares Are Trading Higher Today

Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) with a price target of $12. Following a problematic 4QF22, he noted that Accolade bounced back nicely in 1QF23 as the company beat management's initial outlook for FY23 revenue and adjusted EBITDA. While early in the selling season, ACCD won more new business in 1QF23 than…

Benzinga

Canaccord Genuity Maintains Buy Rating for InMode: Here's What You Need To Know

Canaccord Genuity has decided to maintain its Buy rating of InMode (NASDAQ:INMD) and lower its price target from $50.00 to $40.00. Shares of InMode are trading down 2.15% over the last 24 hours, at $22.76 per share. A move to $40.00 would account for a 75.75% increase from the current…

Benzinga

Crypto Analyst Still Bullish On Bitcoin Miners, Names 4 Top Stock Picks

Plummeting cryptocurrency prices have made life difficult for Bitcoin (CRYPTO: BTC) miners in 2022, but Canaccord Genuity analyst Joseph Vafi said Monday that he maintains his bullish long-term outlook for crypto miners Argo Blockchain ADR (NASDAQ:

Benzinga

This Snowflake Analyst Is Turning Bullish On Innovation, Valuation

Snowflake Inc’s (NYSE: SNOW) analyst day and customer conference highlighted innovations that could lead to higher consumption and better monetization, according to Canaccord Genuity.

Benzinga

Why Snowflake Stock Is Heating Up Today

Snowflake Inc (NYSE: SNOW) shares are trading higher Wednesday following bullish analyst coverage from Canaccord Genuity.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its success on the regulation and approval of scheduled psychoactive substances for mental health and other health indications.

Benzinga

Read How Analysts Reacted To MongoDB Post Q1 Earnings Beat

Analysts appreciated MongoDB, Inc's (NASDAQ:MDB) Q1 beat but cut the price target to reflect macro headwinds. Needham analyst Mike Cikos maintained MongoDB with a Buy rating and lowered the price target from $362 to $310. The price target change reflected the declines in the broader stock market. Cikos acknowledged MongoDB's strong 1QF23 feat outperforming guidance and expectations.…

Insider UK

Adam & Co strengthened by parent's latest acquisition

Deal sees the Edinburgh-based team double in size

Benzinga

Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know

Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga

Canaccord Genuity Maintains Buy Rating for Alphabet: Here's What You Need To Know

Canaccord Genuity has decided to maintain its Buy rating of Alphabet (NASDAQ:GOOGL) and lower its price target from $3500.00 to $3300.00. Shares of Alphabet are trading down 3.63% over the last 24 hours, at $2286.75 per share.

Benzinga

Canaccord Genuity Maintains Buy Rating for Vapotherm, Lowers Price Target To $12

Canaccord Genuity has decided to maintain its Buy rating of Vapotherm (NYSE:VAPO) and lower its price target from $21.00 to $12.00. Shares of Vapotherm are trading down 1.52% over the last 24 hours, at $6.48 per share.

Benzinga

51 Biggest Movers From Yesterday

Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares climbed 79.7% to close at $3.63 on Wednesday. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement.

Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session

Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022

Upgrades

Benzinga

Here's Why Canaccord Is Bullish On This Cryptocurrency Mining Company

Canaccord Genuity analyst Joseph Vafi initiated coverage of HIVE Blockchain Technologies Ltd (NASDAQ:HIVE) with a Buy rating and a $2.80 price target, suggesting an upside of 27%. Digital assets, especially Bitcoin and Ethereum, successfully exited another test of their resiliency in the face of recent market volatility. Vafi expects miners to benefit if bitcoin prices…

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.